NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-67

  1. 942 Posts.
    lightbulb Created with Sketch. 156
    Tony,
    Having a quick read of that paper one could easily extrapolate that trofinitide could be used by everyone to stimulate brain function. I suppose this is where the aspirin for the brain saying has evolved from.

    I have only held Neu for just under three years and whilst there's been some ups and downs your, hottod's and others invaluable posts on HC have alleviated any wavering in holding this stock. A great future for all.
    Last edited by Saus: 08/12/15
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.